Vann Healthcare Recalls Epinephrine Syringes Due to Sterility Concerns
Vann Healthcare Services is recalling 410 epinephrine syringes because an FDA inspection found deficiencies that raise concerns about the pharmacy's ability to assure sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility for a parenteral drug, which carries a significant risk of serious injury or infection.
Plain-English summary
Vann Healthcare Services Inc is recalling 410 syringes of Epinephrine 1:1000, 0.15 mL packaged in 0.3 mL syringes. The product was distributed in Kentucky. The specific lot numbers involved are 06094A, 06254A, 07164A, 08114A, and 08284C.
The recall was initiated following a recent FDA inspection of the Vann Healthcare Services facility. The inspection revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure the sterility of its products.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on how to return or dispose of the medication.
The recalled product
- Product
- Epinephrine 1:1000, 0.15 mL packaged in 0.3 mL syringes, Rx, Vann Healthcare Pharmacy, 1220 N Race Street, Glasgow, KY 42141
- Manufacturer
- Vann Healthcare Services Inc
- Category
- Drug — Injectable Medication
- Affected units
- 410
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #s: 06094A
- 06254A
- 07164A
- 08114A
- and 08284C.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 4 recalled by Vann Healthcare Services Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Vann Healthcare Services Inc
See all →- ModerateVann Healthcare Recalls Hydroxyprogesterone Caproate Due to Sterility Concerns
FDA (Drugs) · 2014-12-31
- SevereVann Healthcare Recalls Lidocaine Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-31
- SevereVann Healthcare Pharmacy Recalls Tri-mix #4 Due to Sterility Concerns
FDA (Drugs) · 2014-12-31
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePharmakon Recalls Epinephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- HighEpinephrine Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-27
- SevereSpecialty Medicine Compounding Pharmacy Recalls Epinephrine Due to Sterility Concerns
FDA (Drugs) · 2014-01-22
- SevereRXQ Compounding Recalls Epinephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- HighEpinephrine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-27
- SeverePharmakon Recalls Epinephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2016-07-20